CAS: 853-34-9; Kebuzone

该化合物是一种化学化合物,主要被确认为非类固醇抗炎药物(NSAID),具有止痛和抗炎特性,有助于治疗疼痛和炎症;该化合物的特点是能够抑制环氧素酶酶,它在合成丙烯菊酯,炎症和疼痛的调解者方面起着关键作用; Kebuzone通常用于各种配方,包括片片和专题应用,以其相对快速的开始行动而著称;其药理学学学涉及吸收,分布,新陈代谢和排泄过程,对于治疗效果至关重要;尽管一般而言,它与许多非典ID一样,它可能具有副作用,包括胃肠道不适或潜在的心血管风险,特别是长期使用.与任何药物一样,用户必须咨询保健专业人员,以便适当使用和讨论与其他药物的任何潜在相互作用.

结构式图片

相似化合物

2652-77-9 19933-22-3 2654-57-1

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号122-66-7 1,2-二苯肼 | CAS号7796-23-8 [2-(2-Methyl-1,... | CAS号10561-01-0 4-[(Z)-3-chloro... | CAS号10553-86-3 (3-chloro-but-2... | CAS号2652-77-9 1,2-二苯-3,5吡唑二酮 | CAS号93371-32-5 2,5-dioxo-N-phe... | CAS号93371-33-6 5,5-dimethoxy-2... | CAS号93371-31-4 2-methoxy-2-(3-... | CAS号93371-35-8 2-(3,3-dimethox... | CAS号1227476-15-4 1,2-diphenyldiazene | CAS号93371-34-7 2-hydroxy-2-(3-...

合成工艺路线路线简述

    📜4-(3-Chloro-But-2-Enyl)-1,2-Diphenyl-Pyrazolidine-3,5-Dione置于硫酸体系中,化学反应生成 酮基保太松
    参考文献:Ctvrtnik Et Al.,Cesko-Slovenska Farmacie,1958,Vol. 7,P. 303
    标题:Ctvrtnik Et Al.,Cesko-Slovenska Farmacie,1958,Vol. 7,P. 303

    海关参考信息

    专利信息


    专利号:US-2012177593-A1
    优先权日:2009-07-20
    标 题 :Synthesis of dendrimer conjugates
    发明人:BAKER JR JAMES R; ZHANG YUEHUA; THOMAS THOMMEY P; DESAI ANKUR MAHESH
    权利人:BAKER JR JAMES R; ZHANG YUEHUA; THOMAS THOMMEY P; DESAI ANKUR MAHESH; UNIV MICHIGAN
    摘要:The present invention relates to novel methods of synthesis of therapeutic and diagnostic dendrimers. In particular, the present invention is directed to novel dendrimer conjugates, novel methods of synthesizing the same, compositions comprising the conjugates, as well as systems and methods utilizing the conjugates (e.g., in diagnostic and/or therapeutic settings (e.g., for the delivery of therapeutics, imaging, and/or targeting agents (e.g., in disease (e.g., cancer, inflammatory disease) diagnosis and/or therapy, pain therapy, etc.)). Accordingly, dendrimer conjugates of the present invention may further comprise at least two different components for targeting, imaging, sensing, and/or providing a therapeutic or diagnostic material and/or monitoring response to therapy. Furthermore, the novel synthesis methods of certain embodiments of the present invention provide significant advantages with regard to total reaction time and simplicity.

    专利号:US-9145368-B2
    优先权日:2011-12-15
    标 题 :Organocatalytic synthesis of chiral pyrazolidines and their analogues
    发明人:KUMAR BOOPATHI SENTHIL; VENKATARAMASUBRAMANIAN VAITHIYANATHAN; SUDALAI ARUMUGAM
    权利人:COUNCIL SCIENT IND RES
    摘要:Disclosed herein is a highly enantio- (75 to 98% ee) and diastereoselective (99 to 100% de) synthesis of functionalized pyrazolidines via tandem a-amination-Corey Chaykovsky reaction of alpha unsubstituted aldehydes.

    专利号:US-9051302-B2
    优先权日:2008-01-15
    标 题 :Synthesis of resorcylic acid lactones useful as therapeutic agents
    发明人:WINSSINGER NICOLAS; BARLUENGA SOFIA; KARPLUS MARTIN
    权利人:WINSSINGER NICOLAS; BARLUENGA SOFIA; KARPLUS MARTIN; UNIV STRASBOURG
    摘要:Disclosed are macrocyclic compounds of formulae I, I′, II, II′, III, III′, IV, and V, which are analogs of the pochonin resorcylic acid lactones, pharmaceutical compositions comprising the compounds, and methods and uses comprising the compounds for the treatment of diseases mediated by kinases and Heat Shock Protein 90 HSP90.

    专利号:US-2015352230-A1
    优先权日:2013-01-11
    标 题:Synthesis and isolation of dendrimer based imaging systems
    发明人:MULLEN DOUGLAS GURNETT; BAKER JR JAMES R; BANASZAK HOLL MARK M; HUANG BAOHUA; DOUGHERTY CASEY; BALL JACK
    权利人:UNIV MICHIGAN
    摘要:The present invention relates to novel methods of synthesis and isolation of antibodies conjugated with modular dendrimer nanoparticles. In particular, the present invention is directed to antibodies conjugated with novel modular dendrimer nanoparticles having precise numbers of imaging agents, methods of synthesizing the same, compositions comprising such antibodies conjugated with such modular dendrimer nanoparticles, as well as systems and methods utilizing the conjugates (e.g., in imaging settings) (e.g., in diagnostic and/or therapeutic settings) (e.g., for the delivery of therapeutics, imaging, and/or targeting agents).

    专利号:US-2012232225-A1
    优先权日:2009-08-26
    标 题:Synthesis and isolation of dendrimer systems
    发明人:BAKER JR JAMES R; BANASZAK HOLL MARK M; MULLEN DOUGLAS GURNETT; ORR BRADFORD G; DESAI ANKUR; SANDER LEONARD M; WADDELL JACK NEEL
    权利人:BAKER JR JAMES R; BANASZAK HOLL MARK M; MULLEN DOUGLAS GURNETT; ORR BRADFORD G; DESAI ANKUR; SANDER LEONARD M; WADDELL JACK NEEL; UNIV MICHIGAN
    摘要:The present invention relates to novel methods of synthesis and isolation of dendrimer systems. In particular, the present invention is directed to novel dendrimer conjugates with defined and limited numbers of ligand conjugates and high levels of structural uniformity, methods of synthesizing the same, compositions comprising the conjugates, as well systems and methods utilizing the conjugates (e.g., in diagnostic and/or therapeutic settings (e.g., for the delivery of therapeutics, imaging, and/or targeting agents (e.g., in disease (e.g., cancer) diagnosis and/or therapy, pain therapy, etc.)).

    专利号:US-9402911-B2
    优先权日:2011-12-08
    标题:Multifunctional small molecules
    发明人:BAKER JR JAMES R; HUANG BAOHUA M; THOMAS THOMMEY P
    权利人:UNIV MICHIGAN REGENTS
    摘要:The present invention relates to dendrimer synthesis. Specifically, the present invention relates to dendrimer compositions (e.g., scaffolds) capable of copper-free click conjugation for use in the synthesis of functionalized dendrimers, and methods of use of the same.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Senra H, Vieira CR, Nicholls EG, Leal I. Depression and experience of vision loss in group of adults in rehabilitation setting: mixed-methods pilot study. J Rehabil Res Dev. 2013;50(9):1301-14. doi: 10.1682/JRRD.2012.08.0138. Czech. Hungarian. Slovak. Czech. German. Slovak. German. Czech. German. Czech. Czech.

    合成参考文献


    摘要:Arzneimittel-Forschung. Drug Research., 8(229), 1958 []
    摘要:S72 | NTUPHTW | Pharmaceutically Active Substances from National Taiwan University | DOI:10.5281/zenodo.3955664
    摘要:Klimes J, Sochor J, Sedlacek J. Solid-phase extraction and HPLC analysis of kebuzone and its metabolites in blood. Pharmazie. 1996 Sep;51(9):651–3.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知